Friday’s Insider Activity: Top Buys and Sells in US Stocks Revealed

This article summarizes the most significant insider buys and sells reported for US stocks on Friday, January 17, 2025.

Top Buys:

American Strategic Investment Co.: Nicholas S. Schorsch, a significant shareholder and sole managing member of Bellevue Capital Partners (WA:), LLC, has substantially increased his stake in the company. Through indirect purchases via Bellevue Capital Partners and related entities, Schorsch and his affiliates now hold 939,187 shares indirectly, while he personally owns 26,559 shares directly. This continued investment in the real estate investment trust highlights ongoing interest from major stakeholders.

RxSight: The Aliso Viejo, California-based company specializing in ophthalmic goods has seen insider buying activity. RxSight maintains a strong financial position with more cash than debt, positioning it well for future growth opportunities in the medical technology sector.

OPKO Health, Inc.: Phillip Frost, CEO and Chairman, purchased 150,000 shares of common stock at a weighted average price of $1.4695, totaling approximately $220,425. The transaction was made through Frost Gamma Investments Trust, bringing Frost’s indirect ownership to 213,186,477 shares, in addition to his direct and other indirect holdings.

Chemung Financial Corp (NASDAQ:): Director Joseph F. Meade IV acquired 592 shares at an average price of $47.33 each, totaling about $28,019. Following this transaction, Meade now holds 3,709.8612 shares, including dividends received through the company’s Dividend Reinvestment Plan.

Kayne Anderson Energy Infrastructure Fund, Inc.: Executive Vice President Harrison James Little purchased 5,000 shares at an average price of $13.0386 per share, totaling approximately $65,193. This acquisition brings his total direct holdings to 5,000 shares, demonstrating confidence in the company’s prospects.

Top Sells:

Tempus AI, Inc.: Bradley A. Keywell, a significant shareholder, sold shares worth approximately $33.1 million over three days. The transactions involved Class A Common Stock sold at prices ranging from $34.82 to $36.04 per share.

Frontier Group Holdings (NASDAQ:), Inc.: CEO Barry Biffle sold 433,000 shares of common stock, generating approximately $3.64 million. The sales were conducted under a pre-established Rule 10b5-1 trading plan. Biffle also exercised stock options to acquire 625,000 shares at $3.9184 per share.

Atlassian (NASDAQ:) Corp: Co-founder and director Scott Farquhar sold 7,948 shares of Class A common stock at prices ranging from $252.14 to $258.43 per share, totaling approximately $2.01 million. The sale was executed under a Rule 10b5-1 trading plan.

Robinhood Markets (NASDAQ:), Inc.: Director Baiju Bhatt sold 90,866 shares of Class A Common Stock at prices ranging from $45.27 to $45.2784 per share, amounting to approximately $4.1 million. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan.

Atlassian Corp: CEO and Co-Founder Michael Cannon-Brookes sold shares totaling $2,010,942 at prices ranging from $252.14 to $258.43 per share. The sale was executed under a Rule 10b5-1 trading plan adopted on February 8, 2024.

Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management’s confidence in the company’s future performance and potential upcoming developments. However, it’s essential to consider these activities alongside other fundamental and technical analysis factors when making investment choices.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.